Activation of alveolar macrophages in asymptomatic HIV-infected individuals

R. Buhl, H. A. Jaffe, K. J. Holroyd, Z. Borok, J. H. Roum, A. Mastrangeli, F. B. Wells, M. Kirby, C. Saltini, Ronald Crystal

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

After the initial infection with HIV, there is evidence of immune dysfunction despite an apparent normal clinical state. In the context that the lung is a major site affected by opportunistic infection during the progression of this immune dysfunction, and that some components of the immune system are activated during early HIV infection, we hypothesized that there may be activation of alveolar macrophages (AM), a key component of the pulmonary host defense system, during the asymptomatic phase of HIV infection. Compared to normals, in HIV-infected individuals the class II MHC molecules DR, DQ, and DP were all expressed more frequently and in greater cell surface density on AM (p < 0.03, all comparisons), and there was increased spontaneous release of superoxide anion (O(·)-2) by AM (p < 0.002). To gain insight into whether the activation of the AM was an inherent property of the cells or dependent on the in vivo milieu, AM were evaluated after 24 h in culture for O(·)-2 release. In contrast to the findings in fresh AM, after 24 h in culture, O(·)-2 release by HIV AM was not different from normals (p > 0.7), suggesting that these AM had been activated in vivo. To assess whether IFN-γ could be mediating these effects, mRNA levels of the IP-10 gene (a gene specifically induced by increased concentrations of IFN- γ) were quantified in AM. Strikingly, the IP-10 gene was expressed only in AM of HIV-seropositive individuals, suggesting the AM had been exposed to IFN-γ in vivo. Overall, these observations are consistent with the concept that the HIV-seropositive state is associated with activation of AM, in part due to local exposure to IFN-γ.

Original languageEnglish
Pages (from-to)1019-1028
Number of pages10
JournalJournal of Immunology
Volume150
Issue number3
Publication statusPublished - 1 Jan 1993
Externally publishedYes

Fingerprint

Alveolar Macrophages
HIV
HIV Infections
Genes
Lung
Opportunistic Infections
Immune System
Cell Count
Messenger RNA

ASJC Scopus subject areas

  • Immunology

Cite this

Buhl, R., Jaffe, H. A., Holroyd, K. J., Borok, Z., Roum, J. H., Mastrangeli, A., ... Crystal, R. (1993). Activation of alveolar macrophages in asymptomatic HIV-infected individuals. Journal of Immunology, 150(3), 1019-1028.

Activation of alveolar macrophages in asymptomatic HIV-infected individuals. / Buhl, R.; Jaffe, H. A.; Holroyd, K. J.; Borok, Z.; Roum, J. H.; Mastrangeli, A.; Wells, F. B.; Kirby, M.; Saltini, C.; Crystal, Ronald.

In: Journal of Immunology, Vol. 150, No. 3, 01.01.1993, p. 1019-1028.

Research output: Contribution to journalArticle

Buhl, R, Jaffe, HA, Holroyd, KJ, Borok, Z, Roum, JH, Mastrangeli, A, Wells, FB, Kirby, M, Saltini, C & Crystal, R 1993, 'Activation of alveolar macrophages in asymptomatic HIV-infected individuals', Journal of Immunology, vol. 150, no. 3, pp. 1019-1028.
Buhl R, Jaffe HA, Holroyd KJ, Borok Z, Roum JH, Mastrangeli A et al. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. Journal of Immunology. 1993 Jan 1;150(3):1019-1028.
Buhl, R. ; Jaffe, H. A. ; Holroyd, K. J. ; Borok, Z. ; Roum, J. H. ; Mastrangeli, A. ; Wells, F. B. ; Kirby, M. ; Saltini, C. ; Crystal, Ronald. / Activation of alveolar macrophages in asymptomatic HIV-infected individuals. In: Journal of Immunology. 1993 ; Vol. 150, No. 3. pp. 1019-1028.
@article{7ac484fedba34430ab761968242fc556,
title = "Activation of alveolar macrophages in asymptomatic HIV-infected individuals",
abstract = "After the initial infection with HIV, there is evidence of immune dysfunction despite an apparent normal clinical state. In the context that the lung is a major site affected by opportunistic infection during the progression of this immune dysfunction, and that some components of the immune system are activated during early HIV infection, we hypothesized that there may be activation of alveolar macrophages (AM), a key component of the pulmonary host defense system, during the asymptomatic phase of HIV infection. Compared to normals, in HIV-infected individuals the class II MHC molecules DR, DQ, and DP were all expressed more frequently and in greater cell surface density on AM (p < 0.03, all comparisons), and there was increased spontaneous release of superoxide anion (O(·)-2) by AM (p < 0.002). To gain insight into whether the activation of the AM was an inherent property of the cells or dependent on the in vivo milieu, AM were evaluated after 24 h in culture for O(·)-2 release. In contrast to the findings in fresh AM, after 24 h in culture, O(·)-2 release by HIV AM was not different from normals (p > 0.7), suggesting that these AM had been activated in vivo. To assess whether IFN-γ could be mediating these effects, mRNA levels of the IP-10 gene (a gene specifically induced by increased concentrations of IFN- γ) were quantified in AM. Strikingly, the IP-10 gene was expressed only in AM of HIV-seropositive individuals, suggesting the AM had been exposed to IFN-γ in vivo. Overall, these observations are consistent with the concept that the HIV-seropositive state is associated with activation of AM, in part due to local exposure to IFN-γ.",
author = "R. Buhl and Jaffe, {H. A.} and Holroyd, {K. J.} and Z. Borok and Roum, {J. H.} and A. Mastrangeli and Wells, {F. B.} and M. Kirby and C. Saltini and Ronald Crystal",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "150",
pages = "1019--1028",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Activation of alveolar macrophages in asymptomatic HIV-infected individuals

AU - Buhl, R.

AU - Jaffe, H. A.

AU - Holroyd, K. J.

AU - Borok, Z.

AU - Roum, J. H.

AU - Mastrangeli, A.

AU - Wells, F. B.

AU - Kirby, M.

AU - Saltini, C.

AU - Crystal, Ronald

PY - 1993/1/1

Y1 - 1993/1/1

N2 - After the initial infection with HIV, there is evidence of immune dysfunction despite an apparent normal clinical state. In the context that the lung is a major site affected by opportunistic infection during the progression of this immune dysfunction, and that some components of the immune system are activated during early HIV infection, we hypothesized that there may be activation of alveolar macrophages (AM), a key component of the pulmonary host defense system, during the asymptomatic phase of HIV infection. Compared to normals, in HIV-infected individuals the class II MHC molecules DR, DQ, and DP were all expressed more frequently and in greater cell surface density on AM (p < 0.03, all comparisons), and there was increased spontaneous release of superoxide anion (O(·)-2) by AM (p < 0.002). To gain insight into whether the activation of the AM was an inherent property of the cells or dependent on the in vivo milieu, AM were evaluated after 24 h in culture for O(·)-2 release. In contrast to the findings in fresh AM, after 24 h in culture, O(·)-2 release by HIV AM was not different from normals (p > 0.7), suggesting that these AM had been activated in vivo. To assess whether IFN-γ could be mediating these effects, mRNA levels of the IP-10 gene (a gene specifically induced by increased concentrations of IFN- γ) were quantified in AM. Strikingly, the IP-10 gene was expressed only in AM of HIV-seropositive individuals, suggesting the AM had been exposed to IFN-γ in vivo. Overall, these observations are consistent with the concept that the HIV-seropositive state is associated with activation of AM, in part due to local exposure to IFN-γ.

AB - After the initial infection with HIV, there is evidence of immune dysfunction despite an apparent normal clinical state. In the context that the lung is a major site affected by opportunistic infection during the progression of this immune dysfunction, and that some components of the immune system are activated during early HIV infection, we hypothesized that there may be activation of alveolar macrophages (AM), a key component of the pulmonary host defense system, during the asymptomatic phase of HIV infection. Compared to normals, in HIV-infected individuals the class II MHC molecules DR, DQ, and DP were all expressed more frequently and in greater cell surface density on AM (p < 0.03, all comparisons), and there was increased spontaneous release of superoxide anion (O(·)-2) by AM (p < 0.002). To gain insight into whether the activation of the AM was an inherent property of the cells or dependent on the in vivo milieu, AM were evaluated after 24 h in culture for O(·)-2 release. In contrast to the findings in fresh AM, after 24 h in culture, O(·)-2 release by HIV AM was not different from normals (p > 0.7), suggesting that these AM had been activated in vivo. To assess whether IFN-γ could be mediating these effects, mRNA levels of the IP-10 gene (a gene specifically induced by increased concentrations of IFN- γ) were quantified in AM. Strikingly, the IP-10 gene was expressed only in AM of HIV-seropositive individuals, suggesting the AM had been exposed to IFN-γ in vivo. Overall, these observations are consistent with the concept that the HIV-seropositive state is associated with activation of AM, in part due to local exposure to IFN-γ.

UR - http://www.scopus.com/inward/record.url?scp=0027153984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027153984&partnerID=8YFLogxK

M3 - Article

C2 - 8380824

AN - SCOPUS:0027153984

VL - 150

SP - 1019

EP - 1028

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -